dengvaxia
Sanofi’s Dengvaxia becomes first FDA-approved dengue vaccine, but with caveats…
May 2, 2019Sales and Marketing FDA, Sanofi, dengue, dengvaxia, pharma
Sanofi has announced that the FDA has granted authorisation to its tetravalent vaccine Dengvaxia for prevention of dengue disease originating …
FDA advisory panel recommends Sanofi’s dengue vaccine in children, but rejects its use in adults
March 11, 2019Sales and Marketing FDA, Sanofi, US, Vaccine, dengue, dengvaxia, pharma
Dengvaxia, Sanofi’s vaccine for dengue fever, has been burdened with further negative scrutiny after the FDA’s vaccine advisory panel passed …
Philippines Department of Justice recommends charges against six Sanofi officials
March 1, 2019Medical Communications Philippines, Sanofi, dengue, dengvaxia, vaccines
The Philippine Justice Ministry has said it has found probably cause to charge officials working for French drugmaker Sanofi over …
Philippines’ FDA halts sales of Sanofi’s dengue vaccine
February 19, 2019Manufacturing and Production, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma
The marketing authorisation for Sanofi’s dengue vaccine Dengvaxia has been revoked in the Philippines after the country’s Food and Drug …
Danger of Sanofi’s dengue vaccine confirmed in new study
June 14, 2018Medical Communications, Research and Development Sanofi, biotech, dengue, dengvaxia, drugs, pharma, pharmaceutical
A study that thoroughly analyses the impact of Sanofi’s dengue vaccine has confirmed what was feared – children without prior …
Sanofi’s controversial dengue vaccine may still hit US market, despite Philippines disaster
March 7, 2018Sales and Marketing FDA, Philippines, Sanofi, US, dengue, dengvaxia, pharma
Sanofi has revealed that the ongoing debacle in the Philippines concerning its dengue vaccine Dengvaxia has not deterred it from …
Philippines’ launches legal action after Sanofi refuses to refund over dengue vaccine damages
February 5, 2018Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma
Sanofi has refused both requests from the Government of the Philippines to refund used doses of its Dengvaxia vaccine as …
Philippines’ Department of Health demands full refund of $70m Dengvaxia programme from Sanofi
January 30, 2018Manufacturing and Production, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma
In the latest development in Sanofi’s Philippines dengue vaccine scandal, the nation’s Department of Health has demanded that the French …
Philippines’ FDA suspends Dengvaxia marketing, Sanofi responds
January 5, 2018Medical Communications, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma
As the Dengvaxia scandal in the Philippines rolls into 2018, it emerges that the country’s Food and Drugs Administration has …
Philippines to investigate “shameless public health scam”
December 4, 2017Sales and Marketing Sanofi, biotech, dengvaxia, drugs, pharma, pharmaceutical
The Philippines has announced that it will investigate how more than 730,000 children received a dengue vaccine, despite safety concerns …
Sanofi’s dengue vaccine rolled out for world’s first public immunisation program
April 4, 2016Sales and Marketing Philippines, Sanofi, Vaccine, children, dengue, dengvaxia, immunisation, prevention, public health
Sanofi, along with its vaccines global business unit Sanofi Pasteur, has announced the beginning of the first public dengue immunisation …
